Exploring the action mechanism of Gegensan in the treatment of alcoholic liver disease based on network pharmacology and bioinformatics

被引:1
|
作者
Yang, Jiakai [1 ]
Zhuang, Qianqian [1 ]
Tang, Ke [1 ]
Liu, Xinli [1 ]
机构
[1] Qilu Univ Technol, Dept Biol Engn, Jinan 250303, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
alcoholic liver disease; differential analysis; Gegensan; molecular docking; network pharmacology; TRADITIONAL CHINESE MEDICINE; FATTY LIVER; PROTEIN; INFORMATION; ACTIVATION; FIBROSIS; DATABASE;
D O I
10.1097/MD.0000000000038315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gegensan (GGS) has been reported for the treatment of alcoholic liver disease (ALD), but its therapeutic mechanism is still unclear. This paper aims to determine the therapeutic mechanism and targets of action of GGS on alcoholic liver disease utilizing network pharmacology and bioinformatics. The active ingredients in GGS were screened in the literature and databases, and common targets of ALD were then obtained from public databases to construct the network diagram of traditional Chinese medicine-active ingredient targets. Based on the common targets, Gene Ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed to find target enrichment pathways, and the core targets were screened out by combining differential analysis and protein-protein interaction network analysis. Molecular docking was performed to verify the binding effect between the core targets and the corresponding active ingredients. ALD and GGS have 84 common targets, corresponding to 91 active ingredients. After subsequent differential analysis and protein-protein interaction network analysis, 10 core targets were identified. Gene Ontology and KEGG enrichment analyses showed that the main BPs corresponding to the common targets included the response to lipopolysaccharide, inflammatory response, etc. The KEGG pathways involved in the regulation of the common targets included the lipid-atherosclerosis pathway and the alcoholic liver disease pathway, etc. Further molecular docking showed that the core targets CYP1A1, CYP1A2, CXCL8, ADH1C, MMP1, SERPINE1, COL1A1, APOB, MMP1, and their corresponding 4 active ingredients, Naringenin, Kaempferol, Quercetin, and Stigmasterol, have a greater docking potential. The above results suggest that GGS can regulate lipid metabolism and inflammatory response in the ALD process, and alleviate the lipid accumulation and oxidative stress caused by ethanol. This study analyzed the core targets and mechanisms of action of GGS on ALD, which provides certain theoretical support for the further development of GGS in the treatment of ALD, and provides a reference for the subsequent research on the treatment of ALD.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Study on the mechanism of action of Scutellaria barbata on hepatocellular carcinoma based on network pharmacology and bioinformatics
    Yang, An-Yin
    Liu, Hong-Li
    Yang, Yong-Feng
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [22] Correction: Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking
    Yingying Tan
    Fanqin Zhang
    Xiaotian Fan
    Shan Lu
    Yingying Liu
    Zhishan Wu
    Zhihong Huang
    Chao Wu
    Guoliang Cheng
    Bing Li
    Jiaqi Huang
    Antony Stalin
    Wei Zhou
    Jiarui Wu
    Chinese Medicine, 18
  • [23] Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation
    Liu, Guanjie
    Yang, Liu
    Tang, Yifei
    Lin, Jiacheng
    Wang, Fang
    Shen, Jie
    Chang, Bin
    Kong, Xiaoni
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 319
  • [24] Exploring the Mechanism of Action Compound-Xueshuantong Capsule in Diabetic Retinopathy Treatment Based on Network Pharmacology
    Li, Haoran
    Li, Biao
    Zheng, Yanlin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [25] Exploring the possible molecular targeting mechanism of Saussurea involucrata in the treatment of COVID-19 based on bioinformatics and network pharmacology
    Zhang, Dongdong
    Wang, Zhaoye
    Li, Jin
    Zhu, Jianbo
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 146
  • [26] Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review
    Zheng, Shihao
    Xue, Chengyuan
    Li, Size
    Zao, Xiaobin
    Li, Xiaoke
    Liu, Qiyao
    Cao, Xu
    Wang, Wei
    Qi, Wenying
    Zhang, Peng
    Ye, Yongan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Exploring the mechanism of YangXue QingNao Wan based on network pharmacology in the treatment of Alzheimer's disease
    Zhang, Yuying
    Guo, Kaimin
    Zhang, Pengfei
    Zhang, Mengying
    Li, Xiaoqiang
    Zhou, Shuiping
    Sun, He
    Wang, Wenjia
    Wang, Hui
    Hu, Yunhui
    FRONTIERS IN GENETICS, 2022, 13
  • [28] Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study
    Gao, Siqi
    Gao, Tingting
    Li, Lizheng
    Wang, Shule
    Hu, Jie
    Zhang, Ruijing
    Zhou, Yun
    Dong, Honglin
    GENES AND NUTRITION, 2024, 19 (01):
  • [29] Exploring the mechanism of ellagic acid against gastric cancer based on bioinformatics analysis and network pharmacology
    Liu, Zhiyao
    Huang, Hailiang
    Yu, Ying
    Li, Lingling
    Shi, Xin
    Wang, Fangqi
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (23) : 3878 - 3896
  • [30] Exploring the mechanism of SLXG for treating nonalcoholic fatty liver disease based on network pharmacology and molecular docking
    Wang, Yang
    Wang, Jiaxing
    Chen, Zitong
    Liu, Bin
    Wang, Wujie
    Li, Yuliang
    MEDICINE, 2025, 104 (06)